Bronchopulmonary Dysplasia Drug Market Analysis by Drug Type and End User Segments
The Bronchopulmonary Dysplasia Drug Market is gaining strong momentum due to the rising global incidence of premature births and increasing survival rates of extremely low birth weight infants. As neonatal care continues to improve, more infants are surviving conditions that previously had high mortality rates, leading to a growing population vulnerable to chronic lung disorders such as BPD....
0 Comments 0 Shares 41 Views 0 Reviews